Cellebrite DI Ltd.
CLBT
$18.25
$0.975.61%
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | 24.82% | 25.66% | 17.45% | 22.55% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 24.82% | 25.66% | 17.45% | 22.55% | |
| Cost of Revenue | 24.79% | 22.96% | -11.39% | -0.51% | |
| Gross Profit | 24.82% | 26.19% | 24.78% | 28.66% | |
| SG&A Expenses | 13.95% | 27.30% | 2.13% | 7.28% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 15.50% | 21.25% | -2.83% | 5.70% | |
| Operating Income | 170.11% | 55.04% | 1,342.30% | 182.57% | |
| Income Before Tax | 29.95% | -235.63% | -71.86% | -195.62% | |
| Income Tax Expenses | 95.22% | 13.74% | 146.23% | 378.79% | |
| Earnings from Continuing Operations | 26.39% | -306.94% | -74.10% | -197.44% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 26.39% | -306.94% | -74.10% | -197.44% | |
| EBIT | 170.11% | 55.04% | 1,342.30% | 182.57% | |
| EBITDA | 109.44% | 42.71% | 1,199.92% | 315.20% | |
| EPS Basic | 30.37% | -683.72% | -75.24% | -205.33% | |
| Normalized Basic EPS | 33.72% | -228.90% | -- | -192.47% | |
| EPS Diluted | 32.59% | -727.13% | -76.92% | -210.17% | |
| Normalized Diluted EPS | 33.72% | -234.58% | -- | -197.66% | |
| Average Basic Shares Outstanding | 5.75% | 5.13% | 4.52% | 3.42% | |
| Average Diluted Shares Outstanding | 5.75% | 0.86% | 5.80% | -2.08% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
